Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,792 | 1,392 | 1,970 | 3,599 | 3,433 |
| Marketable Securities | 78 | 76 | 78 | 83 | 759 |
| Receivables | 1,262 | 856 | 48 | 432 | 427 |
| Inventories | N/A | N/A | 21 | 22 | 23 |
| Other current assets | 0 | 514 | 500 | 3,713 | 2,715 |
| TOTAL | $3,480 | $2,987 | $2,903 | $9,789 | $7,988 |
| Non-Current Assets | |||||
| PPE Net | 572 | 574 | 567 | 597 | 599 |
| Investments And Advances | 4,021 | 3,681 | 3,403 | 871 | 904 |
| Other Non-Current Assets | 2,662 | 2,338 | 3,608 | 2,525 | 2,576 |
| TOTAL | $7,255 | $6,592 | $7,578 | $3,993 | $4,079 |
| Total Assets | $10,735 | $9,580 | $10,481 | $13,783 | $12,067 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,011 | 360 | 452 | 464 | 446 |
| Accrued Expenses | 2,763 | 2,910 | 1,202 | 1,247 | 1,248 |
| Other current liabilities | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $5,075 | $5,544 | $3,894 | $3,646 | $3,664 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 8 |
| Other Non-Current Liabilities | 3,999 | 437 | 965 | 1,045 | 1,126 |
| TOTAL | $3,926 | $800 | $893 | $956 | $1,042 |
| Total Liabilities | $9,000 | $6,343 | $4,787 | $4,602 | $4,705 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,308 | 3,308 | 3,263 | 3,263 | 3,231 |
| Common Shares | 33 | 3 | 33 | 32 | 30 |
| Retained earnings | -56,728 | -54,904 | -50,041 | -46,336 | -44,477 |
| Other shareholders' equity | -619 | -800 | -1,793 | -1,757 | -1,771 |
| TOTAL | $1,735 | $3,236 | $5,693 | $9,181 | $7,361 |
| Total Liabilities And Equity | $10,735 | $9,580 | $10,481 | $13,783 | $12,067 |